We have updated the ordering process to allow all products and services to be purchased with a single PO, please address all POs to Horizon Discovery Biosciences Limited. Contact us for assistance.

CHOSOURCE™ CHO-K1                GS knockout expression platform

Empowering biotherapeutic production

Drive efficiencies during development and production

  • Freedom to choose - any media, vector or CRO/CMO
  • Freedom to operate – no patent or IP risks
  • Maintain profitability throughout product life cycle - royalty-free licensing

Gene editing CHO cell services

  • Improve your CHO cell performance
  • Meet demands for cost-effective biomanufacturing
  • Ensure a clear IP position with freedom to operate

Regulatory Compliant – no royalty fees

Innovative and flexible approach to licensing

News highlights

  • CHOSOURCE™ platform supports development of immunotherapy for autoimmune diseases
  • CHOSOURCE™ platform offered for COVID-19-related therapeutics and diagnostics
  • Multi-product use license of GS knockout CHO K1 cell line granted to NGM Bio
  • Glenmark adopts CHO cell line into biomanufacturing process

Podcast - The CHO cell line - From reliable workhouse to state-of-the-art protein powerhouse

Listen to a podcast produced by Cell Culture Dish with Professor Alan Dickson, Department of Biotechnology, University of Manchester

How does the CHOSOURCE platform help our customers?

See how Elanco, Jounce Therapeutics, and Just-Evotech Biologics have optimized their biotherapeutic workflows with our CHOSOURCE cells.